Immune Thrombocytopenia in Finnish Children and Adolescents: A Population-Based Cohort Study

Lauri-Matti Kulmala1, Henri Aarnivala1,2, Tytti Pokka3,4

  • 1Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.

Insights

Most children with immune thrombocytopenia (ITP) recover quickly. Chronic ITP is more likely with insidious onset, higher platelet counts, and no recent infections, particularly in females.

Area of Science:

  • Pediatric Hematology
  • Immunology

Background:

  • Immune thrombocytopenia (ITP) is the most frequent cause of low platelet counts in children.
  • Understanding ITP diagnostics, patient profiles, and treatments is crucial for pediatric care.

Purpose of the Study:

  • To characterize diagnostics, patient demographics, and treatment approaches for pediatric ITP.
  • To identify risk factors associated with the development of chronic ITP in children.

Main Methods:

  • A cohort study of 403 Finnish children under 16 diagnosed with ITP between 2006 and 2020.
  • Analysis of patient characteristics, disease onset, treatment, and outcomes, including chronic disease development and bleeding events.

Main Results:

  • 65.9% of children recovered within three months; 25.9% developed chronic ITP.
  • Severe bleeding occurred in 3.7% of patients, with no reported intracranial bleeds or deaths.
  • Insidious onset, female gender, older age, higher platelet counts, and absence of recent viral infections were linked to chronic ITP.

Conclusions:

  • The majority of pediatric ITP cases have short, uncomplicated courses.
  • Factors like insidious onset, non-critical platelet counts, and lack of recent infection increase the likelihood of chronic ITP.
Abstract